Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

307 ! Tue, 7/31/2018, 8:30 AM - 10:20 AM CC-West 221
Clinical Trial Design-3 — Contributed Papers
Biopharmaceutical Section
Chair(s): Josephine Asafu-Adjei
8:35 AM Social Media and Clinical Research

Darcy Hille, Merck & Company Inc; T. Ceesay, Merck
8:50 AM Incorporating Historical Information into the Analysis of Clinical Trials- a Case Study

Guochen Song, Biogen; Yiqing Tian, Q2 Sulotions; John Zhong, Biogen; Stacy Lindborg, Biogen Idec
9:05 AM Systematic Review of Test/Estimation Approach in Comparative Cancer Clinical Studies with Time-To-Event Outcomes

Miki Horiguchi, Kitasato University; Hajime Uno, Dana Farber Cancer Institute
9:20 AM Design Considerations in Clinical Trials with Cure Rate Survival Data: a Case Study in Oncology

Grace Liu, Johnson & Johnson; Steven Sun, J&J; Tzu-min Yhe, janssen pharmaceuticals; Tianmeng Lyu, University of Minnesota; Rao Sudhakar, janssen pharmaceuticals; Bruce Xue, Johnson & Johnson China
9:35 AM Multiplicity Adjustment for Multiple Endpoints Testing in Overall and Subgroup Populations
Libo Sun, Janssen Pharmaceutical R&D; Grace Liu, Johnson & Johnson; Rui Qin, Janssen Pharmaceutical R&D
9:50 AM Statistical Leadership in Clinical Trials: Opportunities from the Draft Estimand Guidance

Jonathan Siegel, Bayer HealthCare Pharmaceuticals Inc.
10:05 AM Safety Analysis of Clinical Trials in NDA Submissions

Linyun Zhou, Takeda Global Research & Development